2016 Health Marathon Award supports Portuguese research in the area of neurodegenerative diseases
-
Topics
Uncategorized
-
To share
The 2016 Health Marathon Awards ceremony will take place tomorrow, March 16, at 11 am in the Auditorium of the Center for Chronic Disease Studies at NOVA Medical School | Faculty of Medical Sciences at NOVA University Lisbon.
The 2016 edition of the Health Marathon received 57 entries, and the proposals were evaluated by an international panel of 31 scientists in the field of Neurodegenerative Diseases and by the Health Marathon's scientific council. The two distinguished projects will receive a total amount of 50 thousand Euros, which comes from donations collected during the charity show broadcast by RTP in April 2016, from the support of Biogen (a biotechnology company) and from other funding obtained through various civil society initiatives during the edition.
Cláudia Almeida Gomes , researcher at the Center for Chronic Disease Studies at NOVA Medical School | Faculty of Medical Sciences at NOVA University Lisbon (CEDOC-NMS | FCM), is one of the winners, with the work “Study of the genetic impact on late-onset Alzheimer's disease”. The scientist will receive the Biogen Prize.
The second award-winning project was authored by the researcher at the Center for Neuroscience and Cell Biology at the University of Coimbra – CNC, Rodrigo Cunha , and is the “Study of caffeine derivatives in the inhibition of Alzheimer's disease and as a basis for new medicines”. The researcher from Coimbra will receive the Health Marathon award.
Previous editions of the MdS Awards in Biomedical Research have awarded projects in areas such as cancer and diabetes. In total, the Health Marathon Awards supported 9 scientists in developing their research work in these areas in Portugal.
The MdS Awards are a joint initiative of the Foundation for Science and Technology (FCT) and the Health Marathon Association. The 2016 edition was supported by Biogen, which associated its name with one of the Awards.
The fourth edition will be dedicated to Cardiovascular Diseases.